Delivery Order 36F79719D0153-36C24120N0335
Award Date 1/23/20
Potential Completion Date 8/30/20
Potential Value $82K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $50,142.96 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) to provide LEMTRADA for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. Performance will take place in Cambridge, Massachusetts through September 30, 2021. No set-aside designation was used for this award issued...
- This federal contract award is for the delivery of LEMTRADA INJECTION VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract was awarded to Genzyme Corporation, doing business as Sanofi Genzyme, a global healthcare and pharmaceutical company. It is a firm fixed price delivery order under Genzyme's $659 million Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows the VHA to issue task orders for a...
- Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $17,830.87 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The firm fixed price order is for the provision of eliglustat to the agency's Cambridge, Massachusetts facility, with an anticipated completion date of April 19,...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) to Genzyme Corporation, doing business as Sanofi Genzyme, for the pharmaceutical product Alemtuzumab 12mg/1.2ml Injection Vial (Lemtrada). The order is for $75,125.05 and was issued under Genzyme's Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs contract with the VA. This delivery order has no set-aside designation. Genzyme Corporation is the...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Genzyme Corporation, doing business as Sanofi Genzyme, under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for the specialty pharmaceutical drug alemtuzumab (Lemtrada) and has a ceiling value of $150,854.30. The contract does not have a set-aside designation. Genzyme Corporation serves as the prime...
- This federal contract award is for the delivery of Eliglustat (Cerdelga) 84mg oral capsules to the Puget Sound VA Health Care System. The $144,553.36 firm fixed price delivery order was issued against Genzyme Corporation's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Genzyme Corporation, doing business as Sanofi Genzyme, is the prime contractor for this order, with no set-aside designation...
- This is a federal contract award to Genzyme Corporation, doing business as Sanofi Genzyme, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award has a ceiling value of $161,979.21 and is a delivery order under Genzyme's existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract valued at $659 million. The delivery order is for the specialty pharmaceutical product Cerdelga (eliglustat), which is used to treat Gaucher's disease. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $212,340.40 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Genzyme Corporation for the bulk purchase of 84mg oral capsules of Eliqlustat (Cerdelga). Performance will take place in Cambridge, Massachusetts with no set-aside designation applied. Genzyme Therapeutics Division, doing business as Sanofi Genzyme, will serve as the...
- This firm fixed-price delivery order was awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Genzyme Corporation, doing business as Sanofi Genzyme, for the pharmaceutical product Eliglustat (Cerdelga 84mg) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) contract. The order has a ceiling value of $246,001.38 and a performance period ending on October 26, 2023. Genzyme serves as the prime contractor, with no set-aside designation applied. This...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $265,045.04 firm fixed price delivery order to Genzyme Corporation, doing business under its Genzyme Therapeutics Division, for eliglustat medication. The period of performance is from October 1, 2020 to September 30, 2021. The delivery order was awarded against Genzyme Corporation's Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking...